Renaissance Capital logo

Trius Therapeutics , Nasdaq: TSRX

Developing an antibiotic for serious gram-positive Staph infections.

Industry: Health Care

First Day Return: 0.0%

Industry: Health Care

Developing an antibiotic for serious gram-positive Staph infections.
more less
IPO Data
IPO File Date 11/06/2009
Offer Price $5.00
Price Range $5.00 - $5.00
Offer Shares (mm) 10.0
Deal Size ($mm) $50
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 08/02/2010
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $50
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters San Diego, CA, United States
Founded 2004
Employees at IPO 36
Website www.triusrx.com

Trius Therapeutics (TSRX) Performance